Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 8638

1.

Coxalgia? Call the gynecologist.

Mandato VD, Aguzzoli L, Alberto C, Abrate M, Silvotti M, La Sala GB.

J Minim Invasive Gynecol. 2015 Jan 19. pii: S1553-4650(15)00072-2. doi: 10.1016/j.jmig.2015.01.008. [Epub ahead of print]

PMID:
25614345
[PubMed - as supplied by publisher]
2.

Prolonging the survival of Tsc2 conditional knockout mice by glutamine supplementation.

Rozas NS, Redell JB, McKenna J 3rd, Moore AN, Gambello MJ, Dash PK.

Biochem Biophys Res Commun. 2015 Jan 19. pii: S0006-291X(15)00061-3. doi: 10.1016/j.bbrc.2015.01.039. [Epub ahead of print]

PMID:
25613864
[PubMed - as supplied by publisher]
3.

Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Sahin K, Cross B, Sahin N, Ciccone K, Suleiman S, Osunkoya A, Master V, Harris W, Carthon B, Mohammad R, Bilir B, Wertz K, Moreno CS, Walker CL, Kucuk O.

Arch Biochem Biophys. 2015 Jan 17. pii: S0003-9861(15)00022-3. doi: 10.1016/j.abb.2015.01.006. [Epub ahead of print]

PMID:
25602702
[PubMed - as supplied by publisher]
4.

Advances in the treatment of tuberous sclerosis complex.

Leclezio L, de Vries PJ.

Curr Opin Psychiatry. 2015 Jan 17. [Epub ahead of print]

PMID:
25602245
[PubMed - as supplied by publisher]
5.

A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.

Kong B, Wu W, Cheng T, Schlitter AM, Qian C, Bruns P, Jian Z, J├Ąger C, Regel I, Raulefs S, Behler N, Irmler M, Beckers J, Friess H, Erkan M, Siveke JT, Tannapfel A, Hahn SA, Theis FJ, Esposito I, Kleeff J, Michalski CW.

Gut. 2015 Jan 19. pii: gutjnl-2014-307616. doi: 10.1136/gutjnl-2014-307616. [Epub ahead of print]

PMID:
25601637
[PubMed - as supplied by publisher]
6.

Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy.

Curatolo P.

Pediatr Neurol. 2014 Nov 20. pii: S0887-8994(14)00659-6. doi: 10.1016/j.pediatrneurol.2014.10.028. [Epub ahead of print] Review.

PMID:
25591831
[PubMed - as supplied by publisher]
7.

CT and MR Imaging for Evaluation of Cystic Renal Lesions and Diseases.

Wood CG 3rd, Stromberg LJ 3rd, Harmath CB, Horowitz JM, Feng C, Hammond NA, Casalino DD, Goodhartz LA, Miller FH, Nikolaidis P.

Radiographics. 2015 Jan-Feb;35(1):125-41. doi: 10.1148/rg.351130016.

PMID:
25590393
[PubMed - in process]
8.

New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.

Sun X, Su Y, He Y, Zhang J, Liu W, Zhang H, Hou Z, Liu J, Li J.

Cell Cycle. 2015 Jan 15:0. [Epub ahead of print]

PMID:
25590233
[PubMed - as supplied by publisher]
9.

[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].

Fournier-Del Castillo MC, Melero-Llorente J, Blanco-Beregana M, Robles-Bermejo F, Budke M, Garcia-Fernandez M, Garcia-Penas JJ, Perez-Jimenez MA.

Rev Neurol. 2015 Jan 16;60(2):75-80. Spanish.

PMID:
25583590
[PubMed - in process]
10.

[Efficacy and safety of rapamycin in treatment of children with epilepsy complicated with tuberous sclerosis].

Zou L, Liu Y, Pang L, Ju J, Shi Z, Zhang J, Chen X, Su X, Hu L, Shi X, Yang X.

Zhonghua Er Ke Za Zhi. 2014 Nov;52(11):812-6. Chinese.

PMID:
25582464
[PubMed - in process]
11.

Overt and Occult Vidian Canal involvement in Juvenile Angiofibroma and its possible impact on Recurrence.

Thakar A, Hota A, Seth Bhalla A, Gupta SD, Sarkar C, Kumar R.

Head Neck. 2015 Jan 12. doi: 10.1002/hed.24012. [Epub ahead of print]

PMID:
25581140
[PubMed - as supplied by publisher]
12.

Renal epithelioid angiomyolipoma in a patient with tuberous sclerosis.

Arachchi A, Tey JY, Makris A, Ruljancich P.

ANZ J Surg. 2015 Jan 12. doi: 10.1111/ans.12959. [Epub ahead of print] No abstract available.

PMID:
25580845
[PubMed - as supplied by publisher]
13.

Atypical pearly penile papules mimicking primary syphilis.

Gouveia AI, Borges-Costa J, Soares-Almeida L.

Acta Dermatovenerol Croat. 2014 Dec;22(4):311-2.

PMID:
25580796
[PubMed - in process]
14.

Management of lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

F1000Prime Rep. 2014 Dec 1;6:116. doi: 10.12703/P6-116. eCollection 2014. Review.

PMID:
25580270
[PubMed]
Free PMC Article
15.

Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis.

Yang G, Yang L, Yang X, Shi X, Wang J, Liu Y, Ju J, Zou L.

Exp Ther Med. 2015 Feb;9(2):626-630. Epub 2014 Nov 27.

PMID:
25574245
[PubMed]
Free PMC Article
16.

Angiomyolipoma of the helix without signs of systemic involvement: successful surgical approach.

Tchernev G, Philipov S, Ananiev J, Gulubova M, Chokoeva AA, Tana C, Wollina U.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):611-4.

PMID:
25572741
[PubMed - in process]
17.

Analysis of twenty pediatric cases of tuberous sclerosis complex: Are we doing enough?

Nath J, Dubey A, Pavan R.

Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):23-8. doi: 10.4103/0378-6323.148560.

PMID:
25566892
[PubMed - in process]
Free Article
18.

Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.

Valianou M, Cox AM, Pichette B, Hartley S, Paladhi UR, Astrinidis A.

Cell Cycle. 2015 Jan 7:0. [Epub ahead of print]

PMID:
25565629
[PubMed - as supplied by publisher]
19.

A chinese tuberous sclerosis complex family and a novel tuberous sclerosis complex-2 mutation.

Luo R, Cai Q, Mu D.

Chin Med J (Engl). 2015;128(1):128-30. doi: 10.4103/0366-6999.147860. No abstract available.

PMID:
25563326
[PubMed - in process]
Free Article
20.

[Histopathologic features of epileptogenic brain lesions in infants and children].

Kakita A.

No To Hattatsu. 2014 Nov;46(6):413-7. Japanese.

PMID:
25558583
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk